Colonic Polyps Treatment & Management
- Author: Gregory H Enders, MD, PhD; Chief Editor: BS Anand, MD more...
Some studies have demonstrated that medical treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) decreases the number and the size of colonic polyps. However, NSAIDs, such as sulindac, do not prevent cancer development. These drugs do not yet constitute established therapies or chemopreventives for colonic polyps.
One study suggests that aspirin may be beneficial in reducing the incidence of recurrent colonic polyps, particularly advanced colonic polyps in select patients with a high risk of colon cancer (and coronary artery disease) and an acceptably low risk of gastrointestinal bleeding or hemorrhagic stroke.
Obtain a Surgical consultation; this is critical in patients with multiple polyps, including patients with familial adenomatous polyposis (FAP). Explain and discuss the type and timing of surgery with the patient.
Diet and activity
A regular diet may be continued. The patient can consider calcium and folate supplements to decrease the risk of colonic polyp recurrence.
Activities may be maintained as tolerated.
In the case of a solitary pedunculated polyp, colonoscopic removal can be performed concurrently with the search for other lesions.
Removal of a solitary colonic polyp is usually curative for that lesion. However, a complete colonoscopic examination should be performed because the finding of a single adenomatous polyp confers an increased risk for the development of others. The rate of colonic polyp recurrence (discovered at follow-up colonoscopy) at 1-year postpolypectomy is small, and recurrence may in fact represent missed synchronous lesions. Repeat colonoscopy at 3-12 months is sometimes advocated if there is substantial doubt whether a colonic polyp has been completely resected and/or contains high-grade dysplasia.
Higher risk (eg, large, aggressive appearing) polyps are often marked at the time of resection by injection of ink (“tattooing”). This method helps to locate the site again, either during colonoscopy or surgery, for follow-up examination, biopsy, or resection. Resection of a large, flat or sessile lesion, particularly when it is removed in pieces, or a polyp with a focus of high-grade dysplasia or cancer is often followed by repeat endoscopy in 3 months to confirm complete excision.
In the case of multiple intestinal polyps associated with FAP, resection remains the only feasible option.
Surgical resection may be advocated for large, sessile polyps that are difficult to remove or for advanced colonic polyps that recur despite adequate initial endoscopic treatment.
Several surgical options should be discussed with the patient, including total colectomy, subtotal colectomy with rectal sparing, or segmental resection.
Currently, no firm guidelines exist regarding the prevention of the development of colonic polyps. However, note the following:
Calcium may be modestly protective.
Fiber may also have some activity; the best evidence is for cereal fiber.
Aspirin may be considered in select patients.
Studies have demonstrated that a diet high in antioxidants has no impact on colonic polyp recurrence.
In one study, supplementary folate was also found to have no benefit, although this conclusion bears the caveat that the tested population had substantial basal folate intake. Thus, some folate intake may be protective.
Most gastroenterologists now advocate repeat colonoscopy 5 years following complete removal of a low-risk adenomatous polyp (as defined histologically). Colonoscopy is repeated in 3 years if the polyp has higher-risk features. Repeat colonoscopy may be advised in 3-12 months if the adequacy of polyp removal is a matter of substantial doubt. If no colonic polyps are found at the initial examination, follow-up colonoscopy at approximately 10-year intervals is recommended.
Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology. 2007 Mar. 132(3):874-82. [Medline].
Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006 Nov. 131(5):1400-7. [Medline].
Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011 Sep 28. 306(12):1352-8. [Medline].
Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology. 1987 Nov. 93(5):1009-13. [Medline].
Powell SM. Direct analysis for familial adenomatous polyposis mutations. Mol Biotechnol. 2002 Feb. 20(2):197-207. [Medline].
Kim DH, Pickhardt PJ, Taylor AJ, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2007 Oct 4. 357(14):1403-12. [Medline].
Benson M, Dureja P, Gopal D, Reichelderfer M, Pfau PR. A Comparison of Optical Colonoscopy and CT Colonography Screening Strategies in the Detection and Recovery of Subcentimeter Adenomas. Am J Gastroenterol. 2010 Dec. 105(12):2578-85. [Medline].
Shah JP, Hynan LS, Rockey DC. Management of small polyps detected by screening CT colonography: patient and physician preferences. Am J Med. 2009 Jul. 122(7):687.e1-9. [Medline].
Liedenbaum MH, van Rijn AF, de Vries AH, et al. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening. Gut. 2009 Sep. 58(9):1242-9. [Medline]. [Full Text].
FDA Clears Colon Camera Pill. Medscape. Feb 3 2014. Available at http://www.medscape.com/viewarticle/820087. Accessed: Feb 11 2014.
Hagel AF, Gabele E, Raithel M, et al. Colon capsule endoscopy: Detection of colonic polyps compared with conventional colonoscopy and visualization of extracolonic pathologies. Can J Gastroenterol Hepatol. 2014 Feb. 28(2):77-82. [Medline].
Van Gossum A, Munoz-Navas M, Fernandez-Urien I, et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med. 2009 Jul 16. 361(3):264-70. [Medline].
Itzkowitz SH, Jandorf L, Brand R, et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol. 2007 Jan. 5(1):111-7. [Medline].
Heresbach D, Chauvin P, Hess-Migliorretti A, Riou F, Grolier J, Josselin JM. Cost-effectiveness of colorectal cancer screening with computed tomography colonography according to a polyp size threshold for polypectomy. Eur J Gastroenterol Hepatol. 2010 Jun. 22(6):716-23. [Medline].
Zafar A, Mustafa M, Chapman M. Colorectal polyps: when should we tattoo?. Surg Endosc. 2012 Nov. 26(11):3264-6. [Medline].
Beach R, Chan AO, Wu TT, et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005 Apr. 166(4):1069-75. [Medline].
Burke CA, Choure AG, Sanaka MR, Lopez R. A comparison of high-definition versus conventional colonoscopes for polyp detection. Dig Dis Sci. 2010 Jun. 55(6):1716-20. [Medline].
Bussey HJ, DeCosse JJ, Deschner EE, et al. A randomized trial of ascorbic acid in polyposis coli. Cancer. 1982 Oct 1. 50(7):1434-9. [Medline].
Cohen LB. A color atlas of colorectal lesions. Pazdur R, Hoskins WJ, Wagman L, Coia LR, eds. Cancer Management: A Multidisciplinary Approach. Huntington, NY: Publisher Research & Representation, Inc; 2000. 301-305.
Coia LR, Ellenhorn JDI, Ayoub JP. Colorectal and anal cancers. Pazdur R, Hoskins WJ, Wagman L, Coia LR, eds. Cancer Management: A Multidisciplinary Approach. Huntington, NY: Publisher Research & Representation, Inc; 2000. 273-299.
Cotran RS, Kumar V, Robbins SL. Tumors of the small and large intestines. Cotran R, Kumar V, Robbins S, eds. Pathologic Basis of Disease. 5th ed. Huntington, NY: WB Saunders Company; 1994. 809-822.
Giardiello FM, Offerhaus GJ, DuBois RN. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur J Cancer. 1995 Jul-Aug. 31A(7-8):1071-6. [Medline].
Itzkowitz SH, Kim YS. Colonic polyps and polyposis syndromes. Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisinger & Fordtran's Gastrointestinal and Liver Disease; Pathophysiology, Diagnosis, Management. 6th ed. Philadelphia, Pa: WB Saunders Company; 1998. Vol 2: 1865-1905.
Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996 Oct 18. 87(2):159-70. [Medline].
Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005 Oct. 129(4):1151-62. [Medline].
Logan RF, Grainge MJ, Shepherd VC, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology. 2008 Jan. 134(1):29-38. [Medline].
Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med. 1993 Dec 30. 329(27):1982-7. [Medline].
Regueiro CR. AGA future trends committee report. Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies. Gastroenterology. 2005 Sep. 129(3):1083-103. [Medline].
Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006 May. 130(6):1865-71. [Medline].
Swan MP, Bourke MJ, Alexander S, Moss A, Williams SJ. Large refractory colonic polyps: is it time to change our practice? A prospective study of the clinical and economic impact of a tertiary referral colonic mucosal resection and polypectomy service (with videos). Gastrointest Endosc. 2009 Dec. 70(6):1128-36. [Medline].
Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006 May. 130(6):1872-85. [Medline].